Read More 1 minute read Biotechnology M&A News News 2seventy bio Completes Asset Purchase Agreement with Novo Nordisk Key Highlights Completion of asset purchase agreement: Novo Nordisk acquires Hemophilia A program and gene editing technology. Team… byChris-Anne RoqueJuly 2, 2024